Delivery Order SPE2DB20D2104-SPE2DB24FS34C
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $3,123.96 and a completion date of February 29, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award, valued at $2,577.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler, a respiratory medication, with a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,562.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Advair HFA 115-21 MCG inhalers. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously awarded to Amerisourcebergen Drug Corp by DLA for the provision of a comprehensive range of pharmaceutical...
- This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM26T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,252.17 delivery order is for the supply of 4,562,493,426 units of the Advair HFA 115-21 MCG inhaler, a prescription medication. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 17, 2023. It is not designated with any set-aside...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Advair HFA 230-21 MCG Inhaler 12GM. The $1,853.56 delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award, valued at $2,687.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of June 13, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award, with ID SPE2DB20D2001|SPE2DB22FM59H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,132.57 firm-fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, running through November...
- This federal contract award, identified as SPE2DB22D1017 and SPE2DB24FF7EY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,197.30, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 mcg inhalers. The $12,265.08 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of an Advair HFA 230-21 mcg inhaler product. The Delivery Order contract, valued at $1,987.86, is a Firm Fixed Price arrangement with a completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS34CDelivery Order
This federal contract award, identified as SPE2DB20D2104|SPE2DB24FS34C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,225.08, is for the delivery of Advair HFA 115-21 MCG inhalers. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/31/24 |